サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1409812

固形腫瘍治療の世界市場レポート 2024年

Solid Tumor Cancer Treatment Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
固形腫瘍治療の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

固形腫瘍治療の市場規模は近年急速に拡大しています。2023年の2,005億3,000万米ドルから2024年には2,308億米ドルへと、CAGR15.1%で成長します。固形腫瘍治療の実績は、いくつかの要因によるものです。これには、研究開発の著しい進歩、新薬や治療法の開発と承認の成功、がん罹患率の顕著な上昇、高齢化人口の増加、がん関連問題に対する患者の積極的な擁護活動と意識の高まりなどが含まれます。これらの要因が複合的に、過去一定期間における固形腫瘍治療の進歩と発展を後押ししました。

固形腫瘍治療市場規模は、今後数年で急成長が見込まれます。2028年には年間平均成長率（CAGR）13.5%で3,828億5,000万米ドルに成長します。固形腫瘍治療の今後予想される成長は、いくつかの重要な要因によるものです。これには、個別化医療の採用の増加、免疫療法の著しい進歩、世界の健康課題および新疾患の出現、新薬の規制枠組みおよび承認、ヘルスケア財政および償還モデルの変革などが含まれます。この期間に予測される注目すべき動向には、免疫療法のさらなる発展、精密医療とバイオマーカー同定の拡大、併用療法の使用、デジタルヘルスソリューションの統合、治療アプローチにおける技術革新などが含まれます。

固形腫瘍治療市場は、主にがんの罹患率の増加によって大きな成長が見込まれています。がんは、体細胞の急速かつ制御不能な再生産によって異常増殖することを特徴とする重篤な疾患です。固形腫瘍治療は、がんと診断された患者から固形腫瘍を除去することを目的とした介入を含みます。2022年、米国がん協会は、新たながん患者が2021年の1,898,160人から2022年には1,918,030人に増加すると推定されると報告しています。このようながん罹患率の上昇が、固形腫瘍治療市場の成長を促進する重要な要因となっています。

固形腫瘍治療市場の成長は、世界人口の増加、特に高齢化によってさらに促進されます。社会における高齢者の割合が高くなることを特徴とする高齢化社会は、さまざまな種類の固形腫瘍に関連する独自の課題と複雑さをもたらします。2022年10月の世界保健機関（WHO）の予測によると、2030年までに世界の6人に1人が60歳以上となります。60歳以上の人口は2020年の10億人から2030年には14億人に増加すると予想されています。さらに、60歳以上の世界人口は倍増し、2050年には21億人に達すると予想されています。高齢化率の上昇は、固形腫瘍治療市場の大きな促進要因です。

2023年の固形腫瘍治療市場では北米が最大地域でした。固形腫瘍治療市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 固形腫瘍治療市場の特徴

第3章 固形腫瘍治療市場の動向と戦略

第4章 固形腫瘍治療市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の固形腫瘍治療市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 固形腫瘍治療市場セグメンテーション

  • 世界の固形腫瘍治療市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 化学療法
  • 標的療法
  • 免疫療法
  • ホルモン療法
  • 外科手術処置
  • 世界の固形腫瘍治療市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 乳がん
  • 子宮頸がん
  • 結腸直腸がん
  • 肺がん
  • 前立腺がん
  • その他の用途
  • 世界の固形腫瘍治療市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 研究機関
  • 在宅ケア

第7章 固形腫瘍治療市場の地域および国分析

  • 世界の固形腫瘍治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の固形腫瘍治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋の固形腫瘍治療市場

第9章 中国固形腫瘍治療市場

第10章 インドの固形腫瘍治療市場

第11章 日本の固形腫瘍治療市場

第12章 オーストラリアの固形腫瘍治療市場

第13章 インドネシアの固形腫瘍治療市場

第14章 韓国の固形腫瘍治療市場

第15章 西欧の固形腫瘍治療市場

第16章 英国の固形腫瘍治療市場

第17章 ドイツの固形腫瘍治療市場

第18章 フランスの固形腫瘍治療市場

第19章 イタリアの固形腫瘍治療市場

第20章 スペインの固形腫瘍治療市場

第21章 東欧の固形腫瘍治療市場

第22章 ロシアの固形腫瘍治療市場

第23章 北米固形腫瘍治療市場

第24章 米国の固形腫瘍治療市場

第25章 カナダの固形腫瘍治療市場

第26章 南米固形腫瘍治療市場

第27章 ブラジル固形腫瘍治療市場

第28章 中東の固形腫瘍治療市場

第29章 アフリカの固形腫瘍治療市場

第30章 固形腫瘍治療市場の競合情勢と企業プロファイル

  • 固形腫瘍治療市場の競合情勢
  • 固形腫瘍治療市場の企業プロファイル
    • AstraZeneca plc
    • Amgen Inc.
    • B. Braun Melsungen AG
    • Bristol Myers Squibb &Company
    • Eli Lilly &Company

第31章 世界の固形腫瘍治療市場の競合ベンチマーキング

第32章 世界の固形腫瘍治療市場競争ダッシュボード

第33章 固形腫瘍治療市場における主要な合併と買収

第34章 固形腫瘍治療市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r11350

“Solid Tumor Cancer Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on solid tumor cancer treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for solid tumor cancer treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The solid tumor cancer treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Chemotherapy; Targeted Therapy; Immunotherapy; Hormone Therapy; Surgical Procedures
  • 2) By Application: Breast Cancer; Cervical Cancer; Colorectal Cancer; Lung Cancer; Prostate Cancer; Other Applications
  • 3) By End-Users: Hospitals; Research Institutes; Homecare
  • Companies Mentioned: AstraZeneca plc; Amgen Inc.; B. Braun Melsungen AG; Bristol Myers Squibb & Company; Eli Lilly & Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Solid tumor cancer treatment pertains to addressing abnormal tissue masses that typically lack cysts or liquid regions. These tumors encompass various organs such as the brain, ovary, breast, colon, and others. The proliferation of tumor cells is primarily driven by cancer stem cells undergoing division.

The principal treatments for solid tumor cancer encompass chemotherapy, targeted therapy, immunotherapy, hormone therapy, and surgical interventions. Chemotherapy involves drug-based therapies aimed at halting cell division or eliminating cancer cells to impede their growth. Its applications extend across various cancer types such as breast, cervical, colorectal, lung, prostate, among others. These treatments are utilized across diverse end-users such as hospitals, research institutes, and home care settings.

The solid tumor cancer treatment market research report is one of a series of new reports from The Business Research Company that provides solid tumor cancer treatment market statistics, including solid tumor cancer treatment industry global market size, regional shares, competitors with a solid tumor cancer treatment market share, detailed solid tumor cancer treatment market segments, market trends and opportunities, and any further data you may need to thrive in the solid tumor cancer treatment industry. This solid tumor cancer treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The solid tumor cancer treatment market size has grown rapidly in recent years. It will grow from $200.53 billion in 2023 to $230.8 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The historical growth in solid tumor cancer treatment can be attributed to several contributing factors. These include significant advancements in research and development efforts, the successful development and approvals of novel drugs and treatments, a noticeable rise in cancer incidence rates, the increasing population of aging individuals, and the active advocacy efforts and heightened awareness among patients regarding cancer-related issues. These factors collectively propelled the progress and development in the treatment of solid tumor cancers during the historical period.

The solid tumor cancer treatment market size is expected to see rapid growth in the next few years. It will grow to $382.85 billion in 2028 at a compound annual growth rate (CAGR) of 13.5%. Anticipated growth in the upcoming period for solid tumor cancer treatment is expected due to several key factors. These include the rising adoption of personalized medicine, significant advancements in immunotherapy, the emergence of global health challenges and new diseases, regulatory frameworks and approvals for novel drugs, and transformations in healthcare financing and reimbursement models. Notable trends predicted for this period encompass further developments in immunotherapy, the expansion of precision medicine and biomarker identification, the use of combination therapies, the integration of digital health solutions, and technological innovations in treatment approaches.

The solid tumor cancer treatment market is anticipated to experience significant growth, primarily driven by the increasing incidence of cancer. Cancer is a severe disorder characterized by the rapid and uncontrolled reproduction of the body's cells, resulting in abnormal growth. Solid tumor cancer treatment involves interventions aimed at removing solid tumors from patients diagnosed with cancer. In 2022, the American Cancer Society reported an estimated increase in new cancer cases from 1,898,160 in 2021 to 1,918,030 in 2022. This escalating incidence of cancer is a key factor propelling the growth of the solid tumor cancer treatment market.

The growth of the solid tumor cancer treatment market is further fueled by the rising global population, particularly the aging population. An aging population, characterized by a higher proportion of elderly individuals within a society, poses unique challenges and complexities related to various types of solid tumors. According to the World Health Organization's projection in October 2022, by 2030, one out of every six individuals globally would be 60 years old or older. The population aged 60 and over is expected to increase from 1 billion in 2020 to 1.4 billion by 2030. Moreover, the global population of individuals aged 60 and older is anticipated to double, reaching 2.1 billion by 2050. The rising aging population is a significant driver of the solid tumor cancer treatment market.

Innovation in products and treatments has emerged as a notable trend in the solid tumor cancer treatment market, with major companies actively focusing on introducing new solutions to sustain their market positions. An illustrative example is Shanghai Henlius Biotech, a China-based biopharmaceutical company, which launched the PD-1 inhibitor HANSIZHUANG in March 2022. HANSIZHUANG, the company's first innovative monoclonal antibody, was developed for treating adults with advanced, unresectable, or metastatic MSI-H (microsatellite instability-high) solid tumors unresponsive to prior conventional treatments. This product innovation not only provides fresh hope for patients with MSI-H solid tumors but also aligns with the demand for precision immunotherapy, fostering the high-quality development of China's biopharmaceutical industry in the solid tumor cancer treatment market.

Prominent companies in the solid tumor cancer treatment market are directing their focus towards the development of monitoring platforms that leverage tailored tests, including personalized assays, for precise detection. Personalized assays involve customized laboratory tests or analytical procedures designed to examine specific characteristics or markers unique to an individual, often based on their genetic or molecular profile. An exemplary illustration is Invitae, a US-based medical genetics company, which, in collaboration with the Tracerx consortium at University College London, launched a personalized cancer monitoring platform in March 2022. This platform is specifically designed for the detection of minimal or molecular residual disease in patients with solid tumors. Utilizing personalized assays based on the patient's tumor, the platform identifies circulating tumor DNA (ctDNA) in the blood. These assays play a crucial role in helping clinicians assess patient risk, gauge treatment response, and predict the likelihood of recurrence.

In March 2021, Takeda Pharmaceutical Company, a leading Japan-based multinational pharmaceutical company, acquired Maverick Therapeutics for $525 million. This acquisition provided Takeda with access to Maverick's T-cell engager COBRA platform and a diverse development portfolio, including TAK-186 (MVC-101) and TAK-280, the latter being the main development candidate (MVC-280). Takeda's acquisition of Maverick Therapeutics enables the expansion of its novel immuno-oncology portfolio, facilitating the advancement of redirected immunotherapies specifically designed to target solid tumors. Maverick Therapeutics Inc., the US-based biotechnology company acquired by Takeda, specializes in providing T-cell targeted immunotherapies for solid tumor cancers. This strategic acquisition positions Takeda to enhance its capabilities in developing innovative solutions for treating solid tumors in the cancer treatment market.

Major companies operating in the solid tumor cancer treatment market report are AstraZeneca plc, Amgen Inc., B. Braun Melsungen AG, Bristol Myers Squibb & Company, Eli Lilly & Company, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Olympus Medical Systems, Astellas Pharma Inc., Celgene Corporation, GlaxoSmithKline plc, Takeda Pharmaceutical Company Ltd., Celldex Therapeutics Inc., AbbVie Inc., Bayer AG, Biogen Inc., Eisai Co. Ltd., Exelixis Inc., Genentech Inc., Gilead Sciences Inc., Incyte Corporation, Ipsen Biopharmaceuticals Inc., Janssen Biotech Inc., Karyopharm Therapeutics Inc., Kyowa Kirin Co. Ltd., MedImmune LLC, Medivation Inc., Millennium Pharmaceuticals Inc., MorphoSys AG, Onyx Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Seattle Genetics Inc., Spectrum Pharmaceuticals Inc., Taiho Pharmaceutical Co. Ltd., Tesaro Inc., Verastem Inc., Zymeworks Inc. .

North America was the largest region in the solid tumor cancer treatment market in 2023. The regions covered in the solid tumor cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the solid tumor cancer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The solid tumor cancer treatment market includes revenues earned by entities by treat solid tumor cancer through hormonal therapy, targeted drugs, and immunotherapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Solid Tumor Cancer Treatment Market Characteristics

3. Solid Tumor Cancer Treatment Market Trends And Strategies

4. Solid Tumor Cancer Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Solid Tumor Cancer Treatment Market Size and Growth

  • 5.1. Global Solid Tumor Cancer Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Solid Tumor Cancer Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Solid Tumor Cancer Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Solid Tumor Cancer Treatment Market Segmentation

  • 6.1. Global Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy
  • Hormone Therapy
  • Surgical Procedures
  • 6.2. Global Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Breast Cancer
  • Cervical Cancer
  • Colorectal Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Applications
  • 6.3. Global Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Research Institutes
  • Homecare

7. Solid Tumor Cancer Treatment Market Regional And Country Analysis

  • 7.1. Global Solid Tumor Cancer Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Solid Tumor Cancer Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Solid Tumor Cancer Treatment Market

  • 8.1. Asia-Pacific Solid Tumor Cancer Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Solid Tumor Cancer Treatment Market

  • 9.1. China Solid Tumor Cancer Treatment Market Overview
  • 9.2. China Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Solid Tumor Cancer Treatment Market

  • 10.1. India Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Solid Tumor Cancer Treatment Market

  • 11.1. Japan Solid Tumor Cancer Treatment Market Overview
  • 11.2. Japan Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Solid Tumor Cancer Treatment Market

  • 12.1. Australia Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Solid Tumor Cancer Treatment Market

  • 13.1. Indonesia Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Solid Tumor Cancer Treatment Market

  • 14.1. South Korea Solid Tumor Cancer Treatment Market Overview
  • 14.2. South Korea Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Solid Tumor Cancer Treatment Market

  • 15.1. Western Europe Solid Tumor Cancer Treatment Market Overview
  • 15.2. Western Europe Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Solid Tumor Cancer Treatment Market

  • 16.1. UK Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Solid Tumor Cancer Treatment Market

  • 17.1. Germany Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Solid Tumor Cancer Treatment Market

  • 18.1. France Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Solid Tumor Cancer Treatment Market

  • 19.1. Italy Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Solid Tumor Cancer Treatment Market

  • 20.1. Spain Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Solid Tumor Cancer Treatment Market

  • 21.1. Eastern Europe Solid Tumor Cancer Treatment Market Overview
  • 21.2. Eastern Europe Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Solid Tumor Cancer Treatment Market

  • 22.1. Russia Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Solid Tumor Cancer Treatment Market

  • 23.1. North America Solid Tumor Cancer Treatment Market Overview
  • 23.2. North America Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Solid Tumor Cancer Treatment Market

  • 24.1. USA Solid Tumor Cancer Treatment Market Overview
  • 24.2. USA Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Solid Tumor Cancer Treatment Market

  • 25.1. Canada Solid Tumor Cancer Treatment Market Overview
  • 25.2. Canada Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Solid Tumor Cancer Treatment Market

  • 26.1. South America Solid Tumor Cancer Treatment Market Overview
  • 26.2. South America Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Solid Tumor Cancer Treatment Market

  • 27.1. Brazil Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Solid Tumor Cancer Treatment Market

  • 28.1. Middle East Solid Tumor Cancer Treatment Market Overview
  • 28.2. Middle East Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Solid Tumor Cancer Treatment Market

  • 29.1. Africa Solid Tumor Cancer Treatment Market Overview
  • 29.2. Africa Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Solid Tumor Cancer Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Solid Tumor Cancer Treatment Market Competitive Landscape
  • 30.2. Solid Tumor Cancer Treatment Market Company Profiles
    • 30.2.1. AstraZeneca plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Amgen Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. B. Braun Melsungen AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bristol Myers Squibb & Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Eli Lilly & Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Solid Tumor Cancer Treatment Market Competitive Benchmarking

32. Global Solid Tumor Cancer Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Solid Tumor Cancer Treatment Market

34. Solid Tumor Cancer Treatment Market Future Outlook and Potential Analysis

  • 34.1 Solid Tumor Cancer Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Solid Tumor Cancer Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Solid Tumor Cancer Treatment Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer